Work

Abstract 1726: Preclinical development of APL-045: A selective PERK inhibitor targeting ER stress pathways in cancer

Year: 2025
Type: conference-abstract
Language: English
Subfield: Cell Biology
Open Access status: closed
OpenAlex ID: W4409690730
Cites:
Cited by:
Related to: 10